Search for other works by this author on: ...
Cancer Biology Evolution Program, Integrated Mathematic Oncology Department, Radiology Department, Moffitt Cancer Center, Tampa, Florida. *Corresponding Author: Robert A. Gatenby, Cancer Biology ...
1Centre for Computational Biology, Duke-NUS Medical School, Singapore ...
*Corresponding Author: Anne McTiernan, Public Health Sciences Division, Fred Hutchinson Cancer Center, 1100 Fairview Avenue North, P.O. Box 19024, Seattle, WA 98109. E-mail: [email protected] ...
Revolution Medicines, Redwood City, CA.
Search for other works by this author on: ...
University of Arkansas for Medical Sciences, Little Rock, AR.
PDL1V is a novel vedotin antibody drug-conjugate (ADC) currently in Phase I clinical development for advanced solid tumors as a monotherapy or in combination with pembrolizumab (NCT05208762). The ...
Background:. A critical component of oncogenesis and cancer progression is metabolic re-programming of cells to enable continuous growth. Oncogenic activated signaling pathways can drive de novo ...
Cancer Res (2025) 85 (8_Supplement_1): 6376.
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale—within the United States—of Bavencio ® (avelumab), a ...
1Houston Methodist Neal Cancer Center, Houston, TX.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback